Role of Cytokines and Vaccines in Break through COVID 19 Infections
Author(s) -
Roshan Kumar,
Purabi Saha,
Richard Owusu Nyarko,
Ivan Kahwn,
Edward Amoah Boateng,
Paul Owusu Boateng,
Christian Asum,
Asare Bertram
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i60b34912
Subject(s) - vaccination , covid-19 , immune system , immunity , immunology , medicine , virology , outbreak , disease , infectious disease (medical specialty) , pathology
Background: Despite efforts to develop a COVID-19 vaccine, it has failed to provide long-term immunity and protection against COVID-19 and the newly worrying SARS-CoV-2 coronavirus strains. Understanding cytokines, which are key in generating unique immune responses from pathogenic organisms, is important for creating vaccines.
Objective: In order to better understand cytokines and how the current COVID-19 vaccinations can assist reactivate latent cytokines, the scientific community and the general public must be educated.
Materials and Methods: Medical and scientific indexing sources like PubMed and Google Scholar were used to search for relevant medical and scientific publications.
Results: After vaccination, cytokines in the immune system can be activated, which can help signal chemicals that can increase the immune system's ability to fight against new and break-through COVID 19 infections.
Conclusion: It has been discovered that both the Pfizer-BioNTech and the Moderna vaccines are safe and effective in preventing break through COVID-19 infections, regardless of whether the patient experiences symptoms or not. It is an adenovirus, not an mRNA, that Johnson & Johnson's vaccine is made of.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom